Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nasti

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
British Journal of Cancer|April 6, 2013
Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trialG Nasti, M C Piccirillo, F Izzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohortM Barba, F Sperati, S Stranges, et al.
British Journal of Cancer|April 28, 2005
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancerR V Iaffaioli, R Formato, A Tortoriello, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
British Journal of Cancer|April 6, 2013
Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trialG Nasti, M C Piccirillo, F Izzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohortM Barba, F Sperati, S Stranges, et al.
British Journal of Cancer|April 28, 2005
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancerR V Iaffaioli, R Formato, A Tortoriello, et al.
Pageof 7